Matches in SemOpenAlex for { <https://semopenalex.org/work/W4386889222> ?p ?o ?g. }
Showing items 1 to 85 of
85
with 100 items per page.
- W4386889222 endingPage "1344" @default.
- W4386889222 startingPage "1340" @default.
- W4386889222 abstract "ABSTRACT Background: Low albumin-to-alkaline phosphatase ratio (AAPR) is associated with tumor progression and poor survival outcome in some malignancies. Purpose: We aimed to determine the prognostic value of AAPR in head and neck cancer (HNC) patients underwent concurrent chemoradiotherapy (CCRT). Materials and Methods: We retrospectively reviewed medical records of 342 patients with HNC treated with definitive or adjuvant CCRT from 2007 to 2017. Receiver-operator characteristic curve assessed the cut-off value and predictive accuracy of AAPR for disease progression. Propensity score-matched (PSM) method was performed to balance baseline characteristics. Multivariate Cox regression analyses screened the independent prognostic factors for progression-free survival (PFS) and overall survival (OS). Results: The median follow-up duration was 40 months. The optimal cut-off level of AAPR was 0.523. In the PSM cohort, an AAPR < 0.523 was related to worse PFS and OS (PFS: Hazard ratio [HR], 1.936; 95% confidence interval [CI], 1.212 to 3.249; P = 0.001 and OS: HR, 1.832; 95% CI, 1.117 to 3.478; P = 0.02) compared with those with an AAPR ≥ 0.523. AJCC stage IVA-B also showed poor survival outcome compared with patients with AJCC stage II--III (PFS: HR, 1.855; 95% CI, 1.173 to 2.933; P = 0.008 and OS: HR, 1.905; 95% CI, 1.131 to 3.211; P = 0.015). Conclusions: HNC patients with low AAPR independently have worse survival outcomes than do high AAPR patients. These findings might help physicians predict treatment outcome and guide treatment strategy in patients with HNC underwent CCRT." @default.
- W4386889222 created "2023-09-21" @default.
- W4386889222 creator A5003364311 @default.
- W4386889222 creator A5017556068 @default.
- W4386889222 creator A5060072507 @default.
- W4386889222 creator A5066770624 @default.
- W4386889222 creator A5069540961 @default.
- W4386889222 creator A5076767501 @default.
- W4386889222 creator A5085660248 @default.
- W4386889222 date "2023-01-01" @default.
- W4386889222 modified "2023-10-17" @default.
- W4386889222 title "Low albumin-to-alkaline phosphatase ratio is associated with inferior prognosis in patients with head and neck cancer underwent concurrent chemoradiation: A propensity score-matched analysis" @default.
- W4386889222 cites W133950914 @default.
- W4386889222 cites W1972141103 @default.
- W4386889222 cites W2006957711 @default.
- W4386889222 cites W2020727031 @default.
- W4386889222 cites W2032247757 @default.
- W4386889222 cites W2041487550 @default.
- W4386889222 cites W2065793218 @default.
- W4386889222 cites W2070135407 @default.
- W4386889222 cites W2094296644 @default.
- W4386889222 cites W2112219095 @default.
- W4386889222 cites W2130310310 @default.
- W4386889222 cites W2136150034 @default.
- W4386889222 cites W2145430644 @default.
- W4386889222 cites W2248423512 @default.
- W4386889222 cites W2562047649 @default.
- W4386889222 cites W2594484779 @default.
- W4386889222 cites W2619787031 @default.
- W4386889222 cites W2762484540 @default.
- W4386889222 cites W2912635537 @default.
- W4386889222 cites W3089737039 @default.
- W4386889222 doi "https://doi.org/10.4103/jcrt.jcrt_158_21" @default.
- W4386889222 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37787305" @default.
- W4386889222 hasPublicationYear "2023" @default.
- W4386889222 type Work @default.
- W4386889222 citedByCount "0" @default.
- W4386889222 crossrefType "journal-article" @default.
- W4386889222 hasAuthorship W4386889222A5003364311 @default.
- W4386889222 hasAuthorship W4386889222A5017556068 @default.
- W4386889222 hasAuthorship W4386889222A5060072507 @default.
- W4386889222 hasAuthorship W4386889222A5066770624 @default.
- W4386889222 hasAuthorship W4386889222A5069540961 @default.
- W4386889222 hasAuthorship W4386889222A5076767501 @default.
- W4386889222 hasAuthorship W4386889222A5085660248 @default.
- W4386889222 hasBestOaLocation W43868892221 @default.
- W4386889222 hasConcept C121608353 @default.
- W4386889222 hasConcept C126322002 @default.
- W4386889222 hasConcept C143998085 @default.
- W4386889222 hasConcept C17923572 @default.
- W4386889222 hasConcept C207103383 @default.
- W4386889222 hasConcept C2776530083 @default.
- W4386889222 hasConcept C44249647 @default.
- W4386889222 hasConcept C50382708 @default.
- W4386889222 hasConcept C71924100 @default.
- W4386889222 hasConceptScore W4386889222C121608353 @default.
- W4386889222 hasConceptScore W4386889222C126322002 @default.
- W4386889222 hasConceptScore W4386889222C143998085 @default.
- W4386889222 hasConceptScore W4386889222C17923572 @default.
- W4386889222 hasConceptScore W4386889222C207103383 @default.
- W4386889222 hasConceptScore W4386889222C2776530083 @default.
- W4386889222 hasConceptScore W4386889222C44249647 @default.
- W4386889222 hasConceptScore W4386889222C50382708 @default.
- W4386889222 hasConceptScore W4386889222C71924100 @default.
- W4386889222 hasIssue "5" @default.
- W4386889222 hasLocation W43868892221 @default.
- W4386889222 hasLocation W43868892222 @default.
- W4386889222 hasOpenAccess W4386889222 @default.
- W4386889222 hasPrimaryLocation W43868892221 @default.
- W4386889222 hasRelatedWork W1987872986 @default.
- W4386889222 hasRelatedWork W2022044594 @default.
- W4386889222 hasRelatedWork W2119154902 @default.
- W4386889222 hasRelatedWork W2129866949 @default.
- W4386889222 hasRelatedWork W2133235702 @default.
- W4386889222 hasRelatedWork W2203903734 @default.
- W4386889222 hasRelatedWork W2240094448 @default.
- W4386889222 hasRelatedWork W2557595673 @default.
- W4386889222 hasRelatedWork W3173653403 @default.
- W4386889222 hasRelatedWork W4282920017 @default.
- W4386889222 hasVolume "19" @default.
- W4386889222 isParatext "false" @default.
- W4386889222 isRetracted "false" @default.
- W4386889222 workType "article" @default.